NDC 42023-104
Aplisol
Tuberculin Purified Protein Derivative
Aplisol is a Intradermal Injection in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Tuberculin Purified Protein Derivative.
| Product ID | 42023-104_d8054592-defc-4aa5-9392-700090b9fb20 |
| NDC | 42023-104 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Aplisol |
| Generic Name | Tuberculin Purified Protein Derivative |
| Dosage Form | Injection |
| Route of Administration | INTRADERMAL |
| Marketing Start Date | 2008-04-25 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103782 |
| Labeler Name | Par Pharmaceutical, Inc. |
| Substance Name | TUBERCULIN PURIFIED PROTEIN DERIVATIVE |
| Active Ingredient Strength | 5 [iU]/.1mL |
| Pharm Classes | Skin Test Antigen [EPC],Tuberculosis Skin Test [EPC],Cell-mediated Immunity [PE],Antigens, Bacterial [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |